Beech Tree Labs and its predecessor, Milkhaus Laboratory, have conducted a number of controlled clinical trials that individually and collectively demonstrate the promise of the RMS approach to therapy. Disorders targeted in the successful trials include:

• Multiple sclerosis
• Benign Prostatic Hyperplasia
• Urinary Incontinence
• Chronic Fatigue Syndrome
• Chronic Obstructive Pulmonary Disease
• Herpesvirus Infection
• Chronic Bronchitis
• Cancer (FDA and USDA)
• Myositis (USDA)
• Cardiomyopathy

Validation of this approach is also found in the publication of peer-reviewed papers addressing the mechanism of action and clinical efficacy of Beech Tree’s therapeutic agents.

Visit our Publications page to learn more.